Joel Becker

Joel Becker serves as President and CEO at NeuroPace. NeuroPace operates in the medical devices sector with approximately 240.0 employees. The company is headquartered in Dripping Springs, Texas. NeuroPace generates annual revenue of 79906000.0.

Industry & Role Insights

• • MessageCEO tracks 1,888 executives in the medical devices sector.
• • We have verified contacts for 2 executives at NeuroPace.
• • 6,856 executive contacts are available in Texas.
• • Our database includes 201,469 c suite-level executives.

Amazon CloudFront Salesforce DNS Made Easy Mimecast Outlook Amazon Elastic Load Balancer Microsoft Office 365 Amazon AWS React Active Campaign Facebook Login (Connect) Bootstrap Framework Gravity Forms Greenhouse.io Facebook Custom Audiences Apache Mobile Friendly New Relic Google Analytics Hotjar YouTube Cedexis Radar Adobe Media Optimizer Shutterstock Facebook Widget Google Tag Manager Google Font API WordPress.org Vimeo Remote

biotechnology life sciences medical/dental instruments health care medical equipment manufacturing epilepsy rns system device neuromodulation brain-responsive seizure reduction drug-resistant personalized treatment eeg data quality of life clinical trials patient monitoring data-driven care patient insights seizure management brain activity diagnostic testing medical device fda-approved patient care neurosurgery telehealth neurotechnology critical care neocortical mesial temporal vagus nerve stimulation brain stimulation patient selection patient stories patient empowerment neurology care data analytics healthcare providers treatment optimization brain disorders adverse events patient eligibility safety information care protocols longitudinal studies informed decisions device implantation treatment guidelines support resources community support clinical benefits epilepsy treatment drug-resistant epilepsy brain-responsive neurostimulation personalized therapy real-time monitoring implantable medical devices neuromodulation technology patient-focused care innovative medical devices neurologists patient support data-driven insights quality of life improvement neurological disorders medical technology ai in healthcare global market reach caregiver involvement clinical collaboration patient education responsive neurostimulation healthcare innovation health wellness & fitness medical devices hospital & health care

FF

Frank Fischer Chief Executive Officer and Board Member at NeuroPace

YM

Yahia Megahed CEO at 360Imaging

HA

Hugo Azevedo Chief Technology Officer at 3B Scientific

MP

Marie-Laure Pochon CEO & President at 3DISC

KD

Khanh Duy Co-CEO at 3D-Side

Outreach Guidance — medical devices Sector

Executives like Joel Becker in the medical devices sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at NeuroPace.

How do I reach Joel Becker directly?

Joel Becker's verified email address is available to MessageCEO Pro subscribers. They currently serve as President and CEO at NeuroPace. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Joel Becker work for?

Joel Becker is President and CEO at NeuroPace, a company in the medical devices sector with 240.0 employees. The company is based in Dripping Springs, Texas.

Can I pitch or sell to Joel Becker?

As President and CEO at NeuroPace, Joel Becker is a key decision-maker in the medical devices sector. MessageCEO Pro gives you verified email to reach Joel Becker directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Joel Becker in?

Joel Becker works in the medical devices industry as President and CEO at NeuroPace. MessageCEO provides verified contact information for executives across all major industries.

Is Joel Becker's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Joel Becker's profile is kept up-to-date with the latest available information.

Last updated: May 13, 2026